PI: Stephen Crystal, PhD
Amount: $525,000
Timeline: Feb. 2020 - Nov. 2022
Area: Policy Initiatives
Cohort: Access to Treatment

    on Social:

Integrating Medications for Opioid Use Disorder into Primary Medical Care: Innovative Payer and Provider Strategies for Improving Treatment Engagement, Retention, Outcomes, and Disparities

New Jersey’s Medicaid program eliminated prior authorization requirements for buprenorphine, increased reimbursement for intake assessments, and now pays for navigation and peer support services. This evaluation will assess whether these changes have made care more accessible and improved treatment outcomes, helping to inform payers looking for ways to encourage primary care providers to offer medications for opioid use disorder.